These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 22593175)

  • 1. CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients.
    Rech AJ; Mick R; Martin S; Recio A; Aqui NA; Powell DJ; Colligon TA; Trosko JA; Leinbach LI; Pletcher CH; Tweed CK; DeMichele A; Fox KR; Domchek SM; Riley JL; Vonderheide RH
    Sci Transl Med; 2012 May; 4(134):134ra62. PubMed ID: 22593175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody blockade of IL-2 receptor α during lymphopenia selectively depletes regulatory T cells in mice and humans.
    Mitchell DA; Cui X; Schmittling RJ; Sanchez-Perez L; Snyder DJ; Congdon KL; Archer GE; Desjardins A; Friedman AH; Friedman HS; Herndon JE; McLendon RE; Reardon DA; Vredenburgh JJ; Bigner DD; Sampson JH
    Blood; 2011 Sep; 118(11):3003-12. PubMed ID: 21768296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells.
    Rech AJ; Vonderheide RH
    Ann N Y Acad Sci; 2009 Sep; 1174():99-106. PubMed ID: 19769742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a phase I/II study in metastatic melanoma patients.
    Jacobs JF; Punt CJ; Lesterhuis WJ; Sutmuller RP; Brouwer HM; Scharenborg NM; Klasen IS; Hilbrands LB; Figdor CG; de Vries IJ; Adema GJ
    Clin Cancer Res; 2010 Oct; 16(20):5067-78. PubMed ID: 20736326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo maintenance of human regulatory T cells during CD25 blockade.
    Huss DJ; Mehta DS; Sharma A; You X; Riester KA; Sheridan JP; Amaravadi LS; Elkins JS; Fontenot JD
    J Immunol; 2015 Jan; 194(1):84-92. PubMed ID: 25416807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.
    Sampson JH; Schmittling RJ; Archer GE; Congdon KL; Nair SK; Reap EA; Desjardins A; Friedman AH; Friedman HS; Herndon JE; Coan A; McLendon RE; Reardon DA; Vredenburgh JJ; Bigner DD; Mitchell DA
    PLoS One; 2012; 7(2):e31046. PubMed ID: 22383993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.
    Di Caro V; D'Anneo A; Phillips B; Engman C; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
    Clin Exp Immunol; 2011 Jul; 165(1):60-76. PubMed ID: 21413939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FoxP3+, and not CD25+, T cells increase post-transplant in islet allotransplant recipients following anti-CD25+ rATG immunotherapy.
    Hire K; Ngo DK; Stewart-Maynard KM; Hering B; Bansal-Pakala P
    Cell Immunol; 2012; 274(1-2):83-8. PubMed ID: 22364726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.
    Locke FL; Pidala J; Storer B; Martin PJ; Pulsipher MA; Chauncey TR; Jacobsen N; Kröger N; Walker I; Light S; Shaw BE; Beato F; Laport GG; Nademanee A; Keating A; Socie G; Anasetti C
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):405-411. PubMed ID: 28007665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.
    Fecci PE; Sweeney AE; Grossi PM; Nair SK; Learn CA; Mitchell DA; Cui X; Cummings TJ; Bigner DD; Gilboa E; Sampson JH
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4294-305. PubMed ID: 16857805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of CD4+ CD25+ regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma.
    Heier I; Hofgaard PO; Brandtzaeg P; Jahnsen FL; Karlsson M
    Clin Exp Immunol; 2008 May; 152(2):381-7. PubMed ID: 18341610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of CTL-associated antigen-4 blockade and depletion of CD25 regulatory T cells enhance tumour immunity of dendritic cell-based vaccine in a mouse model of colon cancer.
    Saha A; Chatterjee SK
    Scand J Immunol; 2010 Feb; 71(2):70-82. PubMed ID: 20384858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impaired immune regulation of autoimmune hepatitis is linked to a defective galectin-9/tim-3 pathway.
    Liberal R; Grant CR; Holder BS; Ma Y; Mieli-Vergani G; Vergani D; Longhi MS
    Hepatology; 2012 Aug; 56(2):677-86. PubMed ID: 22371007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.
    De Somer L; Fevery S; Bullens DM; Rutgeerts O; Lenaerts C; Mathieu C; Boon L; Kasran A; Waer M; Billiau AD
    Immunol Lett; 2010 Sep; 133(1):49-53. PubMed ID: 20600326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease.
    Mielke S; Rezvani K; Savani BN; Nunes R; Yong AS; Schindler J; Kurlander R; Ghetie V; Read EJ; Solomon SR; Vitetta ES; Barrett AJ
    Blood; 2007 Sep; 110(5):1689-97. PubMed ID: 17478639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis.
    Longhi MS; Meda F; Wang P; Samyn M; Mieli-Vergani G; Vergani D; Ma Y
    Hepatology; 2008 Feb; 47(2):581-91. PubMed ID: 18220288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25+ T regs with acetylated FoxP3 are associated with immune suppression in human leprosy.
    Kumar S; Naqvi RA; Ali R; Rani R; Khanna N; Rao DN
    Mol Immunol; 2013 Dec; 56(4):513-20. PubMed ID: 23911408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.
    Wiendl H; Gross CC
    Nat Rev Neurol; 2013 Jul; 9(7):394-404. PubMed ID: 23732529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD25 appears non essential for human peripheral T(reg) maintenance in vivo.
    de Goër de Herve MG; Gonzales E; Hendel-Chavez H; Décline JL; Mourier O; Abbed K; Jacquemin E; Taoufik Y
    PLoS One; 2010 Jul; 5(7):e11784. PubMed ID: 20689592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis.
    Zhang Y; McClellan M; Efros L; Shi D; Bielekova B; Tang MT; Vexler V; Sheridan JP
    Mult Scler; 2014 Feb; 20(2):156-64. PubMed ID: 23846354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.